本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Autolus Therapeutics PLC

1.89
-0.0500-2.58%
成交量:51.67萬
成交額:98.01萬
市值:5.03億
市盈率:-1.80
高:1.96
開:1.95
低:1.88
收:1.94
52周最高:2.58
52周最低:1.18
股本:2.66億
流通股本:1.03億
量比:0.49
換手率:0.50%
股息:- -
股息率:- -
每股收益(TTM):-1.0526
每股收益(LYR):-1.0804
淨資產收益率:-133.00%
總資產收益率:-25.44%
市淨率:6.72
市盈率(LYR):-1.75

資料載入中...

2020/04/22

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/03

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/02/11

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/24

超過5%披露

General statement of acquisition of beneficial ownership
2020/01/24

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/09

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/10/09

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/09/20

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/09/16

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/09/09

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/08/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/08

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/07/22

SEC問詢函

[Cover]Correspondence
2019/05/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/08

SEC問詢函

[Cover]Correspondence
2019/04/08

SEC問詢函

[Cover]Correspondence
2019/04/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]